Effectiveness of Different Strategies in Maintaining Target Goals of Cardiovascular Risk Factors in Patients Discharged From Cardiovascular Risk Reduction Clinic
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- The number of patients who had non-compliance to ADA target goals in smoking, LDL cholesterol, blood pressure or Hb A1c.
研究概览
简要总结
The purpose of this study is to determine whether a combined behavioral and pharmacological intervention provided by a multidisciplinary team will further reduce LDL-C, smoking, BP and Hb-A1C in diabetic patients with A1c between 7% and 9% when compared to usual care.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Previous enrollment in Cardiovascular Risk Reduction Clinic (CRRC)
- •Eligible for CRRC discharge:
- •For DM patients:
- •HbA1c < 7.0 %,
- •BP < 130/85 mm Hg , and
- •LDL < 100 mg/dl;
- •For Non-DM patients:
- •BP < 140/90 mm Hg, and
- •LDL < 100 mg/dl;
- •Able and willing to sign informed consent.
排除标准
- •Presence of conditions that might limit long-term compliance (eg, dementia, acute psychiatric decompensation within the previous 6 months, unstable psychiatric disorder);
- •Metastatic disease or terminal illness
研究组 & 干预措施
group intervention
pharmacist-led group intervention in behavioral and pharmacologic therapy
干预措施: Interactive Education (Behavioral)
group intervention
pharmacist-led group intervention in behavioral and pharmacologic therapy
干预措施: Group Support (Behavioral)
group intervention
pharmacist-led group intervention in behavioral and pharmacologic therapy
干预措施: Counseling (Behavioral)
group intervention
pharmacist-led group intervention in behavioral and pharmacologic therapy
干预措施: Pharmacologic case management (Procedure)
individual
pharmacist-based individual clinic visits with behavioral and pharmacologic intervention for cardiac risk reduction
干预措施: Counseling (Behavioral)
individual
pharmacist-based individual clinic visits with behavioral and pharmacologic intervention for cardiac risk reduction
干预措施: Pharmacologic case management (Procedure)
usual care
usual care
结局指标
主要结局
The number of patients who had non-compliance to ADA target goals in smoking, LDL cholesterol, blood pressure or Hb A1c.
时间窗: 12 months
次要结局
未报告次要终点
研究者
Wen-Chih Wu
Staff Cardiologist
Providence VA Medical Center